Waterloo Regional Health Network

Futó vizsgálatok

• Toboroz

  Evaluating Dose Timing (Morning vs Evening) of Endocrine-based Therapies in Metastatic Breast and Prostate Cancers

  NCT07252726· 4. fázis· Forrás

• Fut, nem toboroz

  A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer

  NCT06966453· 1/2. fázis· Forrás

• Toboroz

  Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

  NCT06592924· 3. fázis· Forrás

• Toboroz

  Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate Treatment

  NCT06235697· 3. fázis· Forrás

• Toboroz

  Tracking Results of Ablations to Combat AF Registry Generation 2

  NCT05111015· Forrás

• Toboroz

  Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study

  NCT05987241· 2/3. fázis· Forrás

• Toboroz

  Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

  NCT05879926· 3. fázis· Forrás

• Toboroz

  Type 1 Diabetes Virtual Self-management Education and Support

  NCT05756829· Forrás

• Fut, nem toboroz

  A Study to Learn About a New Medicine Called Vepdegestrant (ARV-471, PF-07850327) in People Who Have Advanced Metastatic Breast Cancer

  NCT05654623· 3. fázis· Forrás

• Toboroz

  Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

  NCT05174169· 2/3. fázis· Forrás

• Fut, nem toboroz

  Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer

  NCT02954874· 3. fázis· Forrás

• Fut, nem toboroz

  Physician/Patient Choice of Either High-Dose Recombinant Interferon Alfa-2B or Ipilimumab, Versus Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery

  NCT02506153· 3. fázis· Forrás

• Fut, nem toboroz

  Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumors

  NCT01841736· 2. fázis· Forrás

• Fut, nem toboroz

  Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery

  NCT01274338· 3. fázis· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Prosztatarák3 toboroz
• 1-es típusú cukorbetegség1 toboroz
• Áttétes emlőrák1 toboroz
• Hólyagrák1 toboroz
• Petefészekrák1 toboroz
• Pitvarfibrilláció1 toboroz
• Vastagbélrák1 toboroz

Kutatók

Ide még nem kötődik kutató.